全球间质干细胞市场规模、份额、趋势和成长分析报告（2026-2034）

预计间质干细胞市场将从 2025 年的 41.3 亿美元成长到 2034 年的 126.6 亿美元，2026 年至 2034 年的复合年增长率为 13.24%。

受再生医学和细胞疗法研究进展的推动，全球间质干细胞市场正经历显着成长。间质干细胞因其在治疗整形外科、自体免疫疾病和心血管疾病方面的潜力而受到广泛研究。临床试验的增加和治疗应用的拓展正在加速该领域的商业性发展。

关键成长要素包括慢性病发生率上升、老年人口增加、干细胞研究经费投入增加。生物製药公司正投资于可扩展的生产流程和冷冻保存技术，以提高产品的一致性和合规性。政府支持和不断扩大的研究合作进一步增强了市场动态。

随着干细胞疗法逐步走向商业化和监管核准，其未来前景依然光明。基因编辑、组织工程和个人化医疗领域的创新可望提升治疗效果。随着再生医学意识的不断增强，间质干细胞市场有望实现持续的长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球间质干细胞市场：依产品与服务划分

• 市场分析、洞察与预测
• 产品（细胞、细胞株、试剂盒、培养基、试剂等）
• 服务

第五章：全球间质干细胞市场：依工作流程类型划分

• 市场分析、洞察与预测
• 细胞获取和分离
• 培养及冷冻保存
• 差异化
• 特征评价

第六章：全球间质干细胞市场：依类型划分

• 市场分析、洞察与预测
• 自体
• 同种

第七章 全球间质干细胞市场：依分离来源划分

• 市场分析、洞察与预测
• 骨髓
• 脐带血
• 週边血
• 输卵管
• 胎儿肝臟
• 肺
• 脂肪组织

第八章：全球间质干细胞市场：依适应症划分

• 市场分析、洞察与预测
• 骨骼和软骨修復
• 心血管疾病
• 发炎和免疫疾病
• 肝病
• 癌症
• GvHD
• 其他的

第九章：全球间质干细胞市场：依应用划分

• 市场分析、洞察与预测
• 疾病建模
• 药物研发和药物发现
• 干细胞库
• 组织工程
• 毒理学测试
• 其他的

第十章：全球间质干细胞市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十一章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十二章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Axol Bioscience Ltd
  • Stemcell Technologies
  • Merck KgaA
  • Lonza
  • Promocell GMBH
  • Cyagen
  • Celprogen Corporation
  • Cellcolabs
  • Stemedica Cell Technologies Inc
  • Cell Applications Inc

The Mesenchymal Stem Cells Market size is expected to reach USD 12.66 Billion in 2034 from USD 4.13 Billion (2025) growing at a CAGR of 13.24% during 2026-2034.

The Global Mesenchymal Stem Cells Market is witnessing significant growth driven by advancements in regenerative medicine and cell therapy research. Mesenchymal stem cells are widely studied for their potential in treating orthopedic disorders, autoimmune diseases, and cardiovascular conditions. Increasing clinical trials and expanding therapeutic applications are accelerating commercial interest in this field.

Major drivers include rising incidences of chronic diseases, growing geriatric populations, and increased funding for stem cell research. Biopharmaceutical companies are investing in scalable manufacturing processes and cryopreservation technologies to improve product consistency and regulatory compliance. Supportive government initiatives and expanding research collaborations further strengthen market dynamics.

Future prospects remain promising as stem cell therapies move toward commercialization and regulatory approvals. Innovations in gene editing, tissue engineering, and personalized medicine are expected to enhance treatment outcomes. As awareness about regenerative therapies grows, the mesenchymal stem cells market is poised for sustained long-term expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Products & Services

• Products (Cells & Cell Lines, Kits, Media, & Reagents, Others)
• Services

By Workflow Type

• Cell Sourcing & Isolation
• Culture & Cryopreservation
• Differentiation
• Characterization

By Type

• Autologous
• Allogenic

By Source of Isolation

• Bone Marrow
• Cord Blood
• Peripheral Blood
• Fallopian Tube
• Fetal Liver
• Lung
• Adipose Tissues

By Indication

• Bone and Cartilage Repair
• Cardiovascular Diseases
• Inflammatory and Immunological Diseases
• Liver Diseases
• Cancer
• GvHD
• Others

By Application

• Disease Modeling
• Drug Development & Discovery
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Axol Bioscience Ltd, Stemcell Technologies, Merck KgaA, Lonza, Promocell GMBH, Cyagen, Celprogen Corporation, Cellcolabs, Stemedica Cell Technologies Inc, Cell Applications Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY PRODUCTS & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Products & Services
• 4.2. Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY WORKFLOW TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Workflow Type
• 5.2. Cell Sourcing & Isolation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Culture & Cryopreservation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Differentiation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Characterization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. Autologous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Allogenic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY SOURCE OF ISOLATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Source Of Isolation
• 7.2. Bone Marrow Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Cord Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Peripheral Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Fallopian Tube Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Fetal Liver Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Lung Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Adipose Tissues Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY INDICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Indication
• 8.2. Bone and Cartilage Repair Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Inflammatory and Immunological Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Liver Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. GvHD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast Application
• 9.2. Disease Modeling Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Drug Development & Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Stem Cell Banking Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Tissue Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.6. Toxicology Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL MESENCHYMAL STEM CELLS MARKET: BY REGION 2022-2034(USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Products & Services
  • 10.2.2 By Workflow Type
  • 10.2.3 By Type
  • 10.2.4 By Source Of Isolation
  • 10.2.5 By Indication
  • 10.2.6 By Application
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Products & Services
  • 10.3.2 By Workflow Type
  • 10.3.3 By Type
  • 10.3.4 By Source Of Isolation
  • 10.3.5 By Indication
  • 10.3.6 By Application
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Products & Services
  • 10.4.2 By Workflow Type
  • 10.4.3 By Type
  • 10.4.4 By Source Of Isolation
  • 10.4.5 By Indication
  • 10.4.6 By Application
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Products & Services
  • 10.5.2 By Workflow Type
  • 10.5.3 By Type
  • 10.5.4 By Source Of Isolation
  • 10.5.5 By Indication
  • 10.5.6 By Application
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 South East Asia
  • 10.5.12 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Products & Services
  • 10.6.2 By Workflow Type
  • 10.6.3 By Type
  • 10.6.4 By Source Of Isolation
  • 10.6.5 By Indication
  • 10.6.6 By Application
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL MESENCHYMAL STEM CELLS INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Thermo Fisher Scientific Inc
  • 12.2.2 Axol Bioscience Ltd
  • 12.2.3 Stemcell Technologies
  • 12.2.4 Merck KgaA
  • 12.2.5 Lonza
  • 12.2.6 Promocell GMBH
  • 12.2.7 Cyagen
  • 12.2.8 Celprogen Corporation
  • 12.2.9 Cellcolabs
  • 12.2.10 Stemedica Cell Technologies Inc
  • 12.2.11 Cell Applications Inc